Singapore markets closed

Straits Times Index
3,307.90
-6.15(-0.19%)
Nikkei
38,729.61
-217.32(-0.56%)
Hang Seng
19,287.51
+66.89(+0.35%)
FTSE 100
8,416.45
-7.75(-0.09%)
Bitcoin USD
70,060.41
-1,160.86(-1.63%)
CMC Crypto 200
1,527.65
+39.11(+2.63%)

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

5.65

+0.04

(+0.71%)

At close: 04:00PM EDT

5.51

-0.14

(-2.48%)

After hours:

06:51PM EDT

Loading interactive chart…

GuruFocus.com
Syros Pharmaceuticals Inc (SYRS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key updates on clinical trials, financial shifts, and strategic insights from Syros Pharmaceuticals' Q1 2024 earnings call.
Thomson Reuters StreetEvents
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Business Wire
Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update
CAMBRIDGE, Mass., May 14, 2024--Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.